ImmuPharma to present at Rodman and Renshaw Annual Global Investment Conference, New York – Tuesday 11 September 2012
7th September 2012 - 11:28 amImmuPharma PLC (LSE:IMM), (“ImmuPharma” or the “Company”), the specialist drug discovery and development company, is pleased to confirm that it will be presenting at the Rodman and Renshaw Annual Global Investment Conference on Tuesday 11 September 2012 at the Waldorf Astoria in New York City. Tracy Weimar, Vice President, Operations and Finance will present an overview of ImmuPharma at 16:55 PM Eastern Time.
If you would like to arrange a one to one meeting with ImmuPharma during this conference between 10-12 September, please do not hesitate to contact either Tracy Weimar, Vice President, Operations and Finance, tracy.weimar@immupharma.com or Lisa Baderoon, Head of Investor Relations, Lisa.baderoon@immupharma.com